The Enzyme That "Un-Toasts" Your Proteins (And What It Actually Means for Aging)

I've read a lot of longevity headlines that turn out to be mice-only or "years away," so when I first heard about an enzyme that reverses skin age from 70+ years to 31 in the All-in Podcast, I went in skeptical. But this one's a little different.

Okay, so what actually happened?

A team from Revel Pharmaceuticals, Calico, and the University of Colorado Anschutz Medical Campus just published a study in Nature Communications about an engineered enzyme called CMLase. Its whole job is to reverse a specific kind of chemical damage that builds up in our proteins as we age. And until now, that damage was considered basically permanent.

Here's the plain-English version of the science:

The "toast" problem. Some proteins in our body, such as collagen in your skin, proteins that keep your arteries flexible, and proteins in your eye's lens, stick around for years or even decades. They're not constantly replaced like a lot of our cells are. Over that long stretch of time, sugar molecules slowly and randomly react with these proteins, kind of like how bread browns when you toast it. That reaction leaves behind a permanent chemical mark called an AGE (advanced glycation end product). The most common one is called CML.

Why it matters. CML isn't just cosmetic damage. It stiffens tissue, distorts protein shape, and can bind to a receptor called RAGE that triggers inflammation. It's been linked to skin aging, artery stiffening, cataracts, and metabolic problems. And the frustrating part has always been that once this damage forms, your body has no way to undo it. It just accumulates, year after year.

The breakthrough. The researchers went looking for an enzyme that could reverse this "browning," basically snipping the sugar tag back off and restoring the original healthy protein. Nothing in nature does this well on its own, so they took a bacterial enzyme that was only weakly capable of the reaction and put it through directed evolution: essentially forcing generations of bacteria to survive only if their enzyme could do this specific repair job, then selecting the best performers and repeating that over and over. After 5 rounds of this, they landed on CMLase.

Did it actually work on real human tissue? This is the part that got my attention. They tested CMLase on real donated human tissue, and the results are astounding.

• In arterial tissue from a 75-year-old donor, CML damage dropped by more than 70%, bringing it down to levels typically seen in someone in their 30s.
• In aged human skin, CML dropped by more than 55%, down below levels seen in 31-year-old skin.
• In lens proteins (the ones in your eye, which are famously long-lived and basically never replaced), CML dropped by 45–78%.

That's a real, measurable reversal of decades-old chemical damage in human tissue. Not a supplement claim, not a mouse study extrapolated to "someday, maybe humans." Actual human samples.

Why this feels like a bigger deal than the usual anti-aging headline

Most longevity science I read about targets things like cellular senescence (zombie cells that won't die) or epigenetic "reprogramming" (resetting a cell's internal clock). This is a different category entirely because it's going after the actual structural damage sitting in your tissue, the stuff that makes skin less elastic and arteries stiffer as you get older. If this class of enzyme therapy eventually works in a living body, the pitch isn't "slow down aging" but it's "remove damage that's already there." That's a genuinely different and exciting angle.

Here's where I'd pump the brakes

I don't want to write this up and let you (or myself) walk away thinking there's a skin cream or injection coming next year. A few real caveats worth sitting with:

• These experiments were done on thin tissue sections, not living skin or a living artery. The researchers themselves note this in the paper. Getting an enzyme to actually penetrate real, intact, living tissue with blood flow, immune cells, and everything else in the mix is a much harder problem than treating a thin slice in a lab dish.
• They didn't test whether the tissue actually functioned better afterward. Reducing the chemical marker (CML) is one thing, but proving the artery is measurably more flexible or the skin measurably more elastic as a result is a separate, harder question they haven't answered yet.
• Immune response is a big unknown. CMLase was built from a bacterial enzyme. Bodies tend to notice and react to bacterial proteins, so whether this could be safely delivered without an immune reaction hasn't been tested at all.
• This only tackles one type of damage. CML happens to be a relatively "easy" AGE to reverse chemically. There's a nastier one called glucosepane that cross-links collagen molecules together and is considered a much bigger driver of stiff, aged tissue. The researchers say that's a much harder problem they haven't cracked yet.
• This is not a product. There's no treatment, no clinical trial (yet), no timeline. This is a proof-of-concept paper showing the chemistry is possible which, to be fair, is exactly what a paper like this is supposed to show.

My honest take

I think this is one of those findings that's genuinely exciting for the field without being personally actionable yet. The significance is that a form of damage long considered irreversible has now been shown, in real human tissue, to be reversible under the right conditions. That's a legitimate scientific first, and it opens a door that a lot of researchers assumed was permanently shut.

I'll be keeping an eye on where Revel takes this next, particularly whether they can show it working in living tissue, not just tissue sections.